Otsuka to Buy Avanir for $3.5 Billion

Japanese drug maker Otsuka Pharmaceutical agreed to buy California-based Avanir Pharmaceuticals in a deal that values the Nasdaq-traded company at $3.5 billion.



from WSJ.com: US Business http://ift.tt/1zd9vMd

via IFTTT